Christopher J Jolles Md Onc - 84096 Herriman, UT

Business Name: Christopher J Jolles Md Onc
Categorized In: Doctors
Address: 12391 South 4000 West # 208, Herriman, UT 84096
Phone Number: (801) 302-5360
Contact Person: Christopher J Jolles
Website Address: specialgyo.com
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 1994
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Peas In A Pod - Herriman, UT 84096
Connolly Michael S MD - Herriman, UT 84096
Harrison Reid MD - Herriman, UT 84096
Kimball Chad MD - Herriman, UT 84096
Devenport Stephen MD - Herriman, UT 84096
Coleby Craig A MD - Herriman, UT 84096
Oelsner David MD - Herriman, UT 84096
Peterson Michael J MD - Herriman, UT 84096
Christensen Peter L MD - Herriman, UT 84096
Bingman Jana MD - Herriman, UT 84096
Radwin Martin MD - Herriman, UT 84096
Riverton Women's Center - Herriman, UT 84096
Elkins Mark MD - Herriman, UT 84096
Schneider Doran J DO - Herriman, UT 84096
Richards Dan DO - Herriman, UT 84096
Special Gyo - Herriman, UT 84096
Families First Pediatrics - Herriman, UT 84096
Clinical Diagnostic Service - Herriman, UT 84096
Gregory A Schwitzer Md - Herriman, UT 84096
Dinger Steven C MD - Herriman, UT 84096

Christopher J Jolles Md Onc provides professional Doctors from its single location at the coordinates 40.525857,-111.98602.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 1994, the company can now be visited at 12391 South 4000 West # 208, Herriman, Utah 84096 or contacted through representative Christopher J Jolles at (801) 302-5360.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Christopher J Jolles Md Onc through its company website at specialgyo.com. Engage with this business on its social media platforms through on Twitter and on Facebook.